Progenics Pharmaceuticals buy Quitte
Start price
18.09.18
/
50%
€5.40
Target price
18.03.19
€7.22
Performance (%)
-24.21%
End price
18.03.19
€4.10
Summary
This prediction ended on 18.03.19 with a price of €4.10. The prediction for Progenics Pharmaceuticals disappointed with a performance of -24.21%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Progenics Pharmaceuticals | - | - | - | - |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by Quitte for this prediction
In the thread Progenics Pharmaceuticals diskutieren
Azedra kommt
https://seekingalpha.com/news/3390597-progenics-adds-azedra-nccn-guidelines-pheochromocytoma-paraganglioma
(Laufzeit überschritten)
Stopped prediction by Quitte for Progenics Pharmaceuticals
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€4.05
22.08.19
22.08.19
€5.00
29.06.20
29.06.20
-8.07%
29.06.20
29.06.20
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€7.50
16.03.18
16.03.18
€9.47
17.09.18
17.09.18
-32.51%
17.09.18
17.09.18
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€3.85
30.01.14
30.01.14
€4.30
25.03.14
25.03.14
-20.86%
25.03.14
25.03.14